Cullen Capital Management, LLC Amgen Inc Transaction History

Cullen Capital Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$255.7 - $288.46 $247,006 - $278,652	-966 Reduced 50.95%	930 $267,000
Q3 2023 Nov 14, 2023	SELL	$218.65 - $271.46 $22,302 - $27,688	-102 Reduced 5.11%	1,896 $509,000
Q2 2023 Aug 14, 2023	SELL	$214.27 - $253.37 $39,211 - $46,366	-183 Reduced 8.39%	1,998 $443,000
Q3 2022 Nov 10, 2022	SELL	$224.46 - $253.15 $17,058 - $19,239	-76 Reduced 3.37%	2,181 $492,000
Q4 2021 Feb 10, 2022	BUY	$198.88 - $227.6 $30,428 - $34,822	153 Added 7.27%	2,257 $508,000
Q3 2021 Nov 05, 2021	SELL	$212.27 - $248.7 $160,476 - $188,017	-756 Reduced 26.43%	2,104 $447,000
Q1 2020 May 05, 2020	BUY	$182.24 - $241.7 $521,206 - $691,262	2,860 New	2,860 $580,000

3,123

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $146B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Cullen Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Cullen Capital Management, LLC with notifications on news.